Press release content from Accesswire. The AP news staff was not involved in its creation.
NBS Capital Inc. Completes Subscription Receipt Financing for Aggregate Proceeds of $5 Million
February 18, 2021 GMT
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWS WIRES
OTTAWA, ON / ACCESSWIRE / February 18, 2021 / NBS Capital Inc. (“NBS” or the “Company”) (TSXV:NBS.P) announces further to its press release of January 4, 2021, that in connection with its proposed scheme of arrangement (the “Arrangement”) with Electric Metals (USA) Limited (“EML”), EML and NBS have completed the non-brokered private placements (the “Financing”) of subscription receipts (the “Subscription Receipts”) in multiple tranches for aggregate gross proceeds of Cdn$5,049,635.13, at a price of Cdn$0.33 per Subscription Receipt. Pursuant to the fully subscribed Financing, EML issued a total of 13,308,407 Subscription Receipts for proceeds of Cdn$4,391,774.85, and NBS issued a tot
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
ClearPoint Neuro, Inc.February 18, 2021 GMT
Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022
IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a worldwide license and research agreement with Philips, a global leader in health technology, to commercialize the ClearPoint ‘Maestro’ Brain Model. The company expects the first-generation anatomical segment analysis tool to be launched in 2022.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Tribune Publishing to be Acquired by Alden Global Capital
February 16, 2021 GMT
CHICAGO, Feb. 16, 2021 /PRNewswire/ Tribune Publishing Company (NASDAQ: TPCO) (“Tribune” or the “Company”) and affiliates of Alden Global Capital (“Alden”) today announced that they have entered into a definitive merger agreement under which Alden will acquire all of the outstanding shares of Tribune common stock not currently owned by Alden for $17.25 per share in cash. Alden currently owns 11,554,306 shares of Tribune common stock, representing 31.6% of the Company’s outstanding shares.
The purchase price represents a premium of 45% to the closing price of Tribune common stock on December 11, 2020, the last trading day prior to receiving Alden’s proposal, a premium of approximately 35% to the closing price of Tribune common stock on December 30, 2020, the last trading day prior to public dis
Press release content from Business Wire. The AP news staff was not involved in its creation.
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
February 17, 2021 GMT
NEW YORK & MAINZ, Germany (BUSINESS WIRE) Feb 17, 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY ®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses.
ADVERTISEMENT
This new agreement is in addition to the 300 million doses that have already been committed to the EU through 2021 under the first supply agreement signed last year. The additional 200 million doses are expected to be delivered in 2021, with an estimated 75 million to be supplied in the second quarter.